Harmonizing immunogenicity for AAV and LNP/mRNA modalities: best-practice panels for binding, neutralizing, and cellular assays with pre-existing immunity controls
Authors:
- 22 January 2026
- journal article
- Published by Taylor & Francis in Bioanalysis
- Vol. 18 (2) , 199-215
Abstract
No abstract availableThis publication has 69 references indexed in Scilit:
- Polyglycerol‐Based Lipids: A Next‐Generation Alternative to PEG in Lipid Nanoparticles for Advanced Drug Delivery SystemsMacromolecular Rapid Communications, 2025
- Ultrasensitive Digital Immunoassay in Homogenous Format by Singlet‐Oxygen Activated Up‐conversion LuminescenceAngewandte Chemie International Edition, 2025
- An Assay for Immunogenic Detection of Anti‐PEG AntibodyChemBioChem, 2024
- Soluble terminal complement complex blood levels are elevated in schizophreniaEuropean Archives of Psychiatry and Clinical Neuroscience, 2024
- Development of anti-PEG IgG/IgM/IgE ELISA assays for profiling anti-PEG immunoglobulin response in PEG-sensitized individuals and patients with alpha-gal allergyJournal of Controlled Release, 2024
- Accelerated blood clearance of PEGylated nanoparticles induced by PEG-based pharmaceutical excipientsJournal of Controlled Release, 2023
- A sensitive and drug tolerant assay for detecting anti-AAV9 antibodies using affinity capture elutionJournal of Immunological Methods, 2022
- Adenovirus vector and mRNA vaccines: Mechanisms regulating their immunogenicityEuropean Journal of Immunology, 2022
- Anti-PEG IgE in anaphylaxis associated with polyethylene glycolThe Journal of Allergy and Clinical Immunology: In Practice, 2021
- Pre-existing anti-PEG antibodies are associated with severe immediate allergic reactions to pegnivacogin, a PEGylated aptamerJournal of Allergy and Clinical Immunology, 2016